Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Two products fuelling Actelion’s growth spurt

March 2, 2007 Sales and Marketing

Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …
News

US approval for Shire’s Vyvanse

February 28, 2007 Sales and Marketing

Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …
News

Helping UK pharma communicate

February 28, 2007 Medical Communications, Sales and Marketing HCA, assocation, public relations

The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …
Feature

Radical overhaul of NHS prescription drug prices recommended

February 20, 2007 Sales and Marketing pricing

 The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …
News

Pfizer to submit evidence to NICE inquiry

February 16, 2007 Sales and Marketing

Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …
News

Sanofi-Aventis growth stifled by Plavix and price cuts

February 15, 2007 Sales and Marketing

Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …
News

NICE set to appraise obesity treatment Accomplia

February 14, 2007 Sales and Marketing

Sanofi-Aventis' obesity treatment Acomplia (rimonabant) will be among the drugs appraised by NICE in its latest works programme. With an …
News

New anti-clotting antibody enters trials

February 12, 2007 Research and Development, Sales and Marketing

European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …
News

Flexing pharma’s competitive muscles

February 12, 2007 Sales and Marketing sales, strategy

It is universally acknowledged, almost to the point of cliche, that pharmaceutical companies operate in a highly competitive environment. Ensuring …
Feature

GlaxoSmithKline plans five launches for 2007

February 9, 2007 Sales and Marketing GSK

GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …
News

Cholesterol drugs boost Schering-Plough

February 9, 2007 Sales and Marketing Merck, Schering-Plough

A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …
News

3,000 job losses to help AZ maintain profits and invest in R&D

February 9, 2007 Sales and Marketing AZ

AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …
News

Go-ahead for free prescriptions in Wales despite warnings

February 9, 2007 Sales and Marketing NHS, Wales

 Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …
News

Novartis set for ‘unprecedented’ wave of launches

February 9, 2007 Sales and Marketing

Novartis is preparing to set a new record for the pharmaceutical industry by launching eight  products in the next 12 …
News

50% drop in UK sales positions reveals fast-changing industry

February 9, 2007 Sales and Marketing

Newly released figures show the number of sales representatives taking the ABPI exam dropped 50% in 2006; clear proof that …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026